Related Experiment Video

Updated: Jun 6, 2025

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.1K

Genetics and Molecular Pathogenesis of the Chondrosarcoma: A Review of the Literature

Georgian-Longin Iacobescu1,2, Antonio-Daniel Corlatescu1, Bogdan Serban1,2

  • 1Department of Orthopedics and Traumatology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Current Issues in Molecular Biology
|November 26, 2024
PubMed

Insights

Chondrosarcoma, a bone tumor, is hard to treat. New genetic markers may help diagnose, predict outcomes, and guide personalized treatments for this challenging cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Chondrosarcoma is a challenging bone tumor resistant to conventional therapies.
  • Surgical removal is standard, but high-grade tumors often recur or metastasize.
  • Reliable diagnostic and prognostic biomarkers are crucial for effective chondrosarcoma management.

Purpose of the Study:

  • To review genetic alterations and molecular pathways in chondrosarcoma pathogenesis.
  • To highlight the potential of molecular markers for diagnosis and prognosis.
  • To discuss implications for personalized therapeutic strategies.

Main Methods:

  • Literature review of genetic alterations in chondrosarcoma.
  • Analysis of molecular pathways implicated in tumor development.
  • Evaluation of biomarker potential for clinical application.

Main Results:

  • Identified key genetic changes and molecular pathways in chondrosarcoma.
  • Highlighted biomarkers that can differentiate tumor types and grades.
  • Demonstrated potential for assessing tumor aggressiveness and guiding treatment decisions.

Conclusions:

  • Genetic and molecular markers show promise for chondrosarcoma diagnosis and prognosis.
  • These biomarkers could enable more personalized and targeted treatment strategies.
  • Further clinical validation is essential to improve patient outcomes.
Keywords:
biomarkerschondrosarcomagenetic alterationsmolecular pathwayspersonalized therapy

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.0K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.0K